San Diego – May 25, 2016 – Rady Children’s Institute for Genomic Medicine is hosting genomics researchers from across the nation to confer on their progress in determining whether sequencing of newborns’ genomes can provide useful medical information beyond what current newborn screening already provides.
The Newborn Sequencing In Genomic medicine and public HealTh (NSIGHT) program addresses how genomic sequencing can replicate or augment known screening results for newborn disorders, what knowledge sequencing can provide for conditions not currently screened, and what additional clinical information could be learned from sequencing relevant to the clinical care of newborns.
The NSIGHT program is funded by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) and the National Human Genome Research Institute (NHGRI), components of the National Institutes of Health.
In fiscal year 2013, initial funding of $5 million was given to four grantees under the Genomic Sequencing and Newborn Screening Disorders research program. The program, currently in its third year, is set to provide funding of $25 million over five years.
The participating grantees in the NSIGHT program include:
- Rady Children’s Institute for Genomic Medicine, Rady Children’s Hospital – San Diego and Children’s Mercy – Kansas City
- Boston Children’s Hospital, Brigham and Women’s Hospital & Baylor College of Medicine
- The University of California, San Francisco and the California Department of Public Health
- The University of North Carolina at Chapel Hill
In addition to NSIGHT program participants, speakers will include scientific leaders from Inova Translational Medicine Institute, Pacific Biosciences, 10X Genomics, Parabase Genomics and DNAnexus.
The conference is May 25, from 8am – 4pm and May 26, from 8am-noon at the Estancia La Jolla Hotel & Spa. Members of the media are welcome and should contact Ben Metcalf to arrange attendance.
(858) 966-8579(o) (619) 822-8593 (c)
About Rady Children’s Institute for Genomic Medicine:
Rady Children’s Institute for Genomic Medicine was founded by Rady Children’s Hospital – San Diego to bring together world-class scientists and clinicians into shared research infrastructure for accelerated translation of research discoveries into prevention, early diagnosis, precise treatments and cures for childhood diseases at Rady Children’s Hospital. This integrated approach to precision medicine includes genomics, epigenomics, metabolomics, proteomics and informatics. This research provides a comprehensive view of a child’s health status and risk factors for disease. www.rchsd.org/research/genomics-institute/